APEN
Income statement / Annual
Last year (2022), Apollo Endosurgery, Inc.'s total revenue was $76.86 M,
an increase of 22.01% from the previous year.
In 2022, Apollo Endosurgery, Inc.'s net income was -$39.84 M.
See Apollo Endosurgery, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$76.86 M |
$62.99 M |
$42.05 M |
$50.71 M |
$60.85 M |
$64.31 M |
$64.87 M |
$1.60 M |
$5.08 M |
$7.99 M |
| Cost of Revenue |
$34.43 M
|
$28.03 M
|
$19.81 M
|
$25.04 M
|
$27.66 M
|
$24.58 M
|
$25.26 M
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$42.43 M
|
$34.96 M
|
$22.24 M
|
$25.68 M
|
$33.19 M
|
$39.73 M
|
$39.61 M
|
$1.60 M
|
$5.08 M
|
$7.99 M
|
| Gross Profit Ratio |
0.55
|
0.56
|
0.53
|
0.51
|
0.55
|
0.62
|
0.61
|
1
|
1
|
1
|
| Research and Development Expenses |
$11.91 M
|
$9.52 M
|
$7.67 M
|
$10.38 M
|
$12.18 M
|
$8.30 M
|
$7.81 M
|
$8.51 M
|
$18.13 M
|
$11.34 M
|
| General & Administrative Expenses |
$20.58 M
|
$18.45 M
|
$11.06 M
|
$13.59 M
|
$13.44 M
|
$13.72 M
|
$13.63 M
|
$3.95 M
|
$4.76 M
|
$4.23 M
|
| Selling & Marketing Expenses |
$36.01 M
|
$24.31 M
|
$17.36 M
|
$28.73 M
|
$32.83 M
|
$32.91 M
|
$31.75 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$56.59 M
|
$42.76 M
|
$28.42 M
|
$42.32 M
|
$46.27 M
|
$46.63 M
|
$45.38 M
|
$3.95 M
|
$4.76 M
|
$4.23 M
|
| Other Expenses |
$1.75 M
|
$1.88 M
|
$1.95 M
|
$2.10 M
|
$7.07 M
|
$7.24 M
|
$7.19 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$70.25 M
|
$54.16 M
|
$38.04 M
|
$54.80 M
|
$65.52 M
|
$62.17 M
|
$60.37 M
|
$12.46 M
|
$22.89 M
|
$15.58 M
|
| Cost And Expenses |
$104.68 M
|
$82.19 M
|
$57.84 M
|
$79.84 M
|
$93.18 M
|
$86.75 M
|
$85.63 M
|
$12.46 M
|
$22.89 M
|
$15.58 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$4.67 M
|
$8.32 M
|
$5.25 M
|
$4.05 M
|
$4.06 M
|
$4.51 M
|
$18.17 M
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
-$196.00 K
|
$2.01 M
|
$2.31 M
|
$2.50 M
|
$9.29 M
|
$9.72 M
|
$9.09 M
|
$466.99 K
|
$216.09 K
|
$196.22 K
|
| EBITDA |
-$31.42 M |
-$14.19 M |
-$11.88 M |
-$26.21 M |
-$40.09 M |
-$12.76 M |
-$20.76 M |
-$9.54 M |
-$17.81 M |
-$7.59 M |
| EBITDA Ratio |
-0.41
|
-0.23
|
-0.28
|
-0.52
|
-0.66
|
-0.2
|
-0.32
|
-5.97
|
-3.5
|
-0.95
|
| Operating Income Ratio |
-0.36
|
-0.3
|
-0.38
|
-0.57
|
-0.66
|
-0.35
|
-0.32
|
-6.79
|
-3.5
|
-0.95
|
| Total Other Income/Expenses Net |
-$7.83 M
|
-$5.33 M
|
-$6.68 M
|
$1.97 M
|
-$5.50 M
|
-$4.55 M
|
-$20.02 M
|
$850.05 K
|
$1.25 M
|
$1.03 M
|
| Income Before Tax |
-$39.26 M
|
-$24.53 M
|
-$22.47 M
|
-$27.16 M
|
-$45.60 M
|
-$26.99 M
|
-$40.78 M
|
-$10.01 M
|
-$16.56 M
|
-$6.56 M
|
| Income Before Tax Ratio |
-0.51
|
-0.39
|
-0.53
|
-0.54
|
-0.75
|
-0.42
|
-0.63
|
-6.26
|
-3.26
|
-0.82
|
| Income Tax Expense |
$584.00 K
|
$156.00 K
|
$142.00 K
|
$275.00 K
|
$191.00 K
|
$304.00 K
|
$387.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$39.84 M
|
-$24.68 M
|
-$22.61 M
|
-$27.43 M
|
-$45.79 M
|
-$27.29 M
|
-$41.17 M
|
-$10.01 M
|
-$16.56 M
|
-$6.56 M
|
| Net Income Ratio |
-0.52
|
-0.39
|
-0.54
|
-0.54
|
-0.75
|
-0.42
|
-0.63
|
-6.26
|
-3.26
|
-0.82
|
| EPS |
-0.98 |
-0.82 |
-0.99 |
-1.27 |
-2.31 |
-2.01 |
-105.69 |
-29.95 |
-77 |
-37.61 |
| EPS Diluted |
-0.98 |
-0.82 |
-0.99 |
-1.27 |
-2.31 |
-2.01 |
-105.69 |
-29.95 |
-77 |
-37.61 |
| Weighted Average Shares Out |
$40.65 M
|
$30.24 M
|
$22.76 M
|
$21.54 M
|
$19.79 M
|
$13.57 M
|
$389.50 K
|
$334.22 K
|
$215.01 K
|
$174.53 K
|
| Weighted Average Shares Out Diluted |
$40.65 M
|
$30.24 M
|
$22.76 M
|
$21.54 M
|
$19.79 M
|
$13.57 M
|
$389.50 K
|
$334.22 K
|
$215.01 K
|
$174.53 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
